Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis

Joshua F. Baker, Erica Billig, Kaleb D Michaud, Said Ibrahim, Liron Caplan, Grant W. Cannon, Andrew Stokes, Vikas Majithia, Ted R Mikuls

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objective In contrast to what is observed in the general population, a low body mass index (BMI) has been associated with accelerated mortality in patients with rheumatoid arthritis (RA). The aim of this study was to assess whether weight loss might explain these seemingly paradoxical observations. Methods Our study included patients identified from the Veterans Affairs (VA) RA Registry. Dates of death were abstracted from VA electronic medical records. The BMI at each study visit and the change from the previous visit were determined. The maximum BMI of each patient was also obtained from medical records. The annualized rate of BMI loss was determined from the slope of change (per year) in BMI over visits within the preceding 13 months. Cox multivariable proportional hazards models were used to assess associations between BMI measures and mortality. Results In a sample of 1,674 patients, 312 deaths occurred over 9,183 person-years. A loss in BMI of ≥1 kg/m2 was associated with a greater risk of death, after adjustment for demographics, comorbidities, BMI, smoking, and RA therapies (hazard ratio [HR] 1.99, 95% confidence interval [95% CI] 1.53-2.59, P<0.001). This association remained significant in a subsample analysis adjusting for C-reactive protein and physical function (HR 1.81, 95% CI 1.36-2.41, P<0.001). Weight loss at an annualized rate of ≥3 kg/m2 was associated with the greatest risk of death (HR 2.49, 95% CI 1.73-3.57, P<0.001). Low BMI (<20 kg/m2) in patients with a history of obesity (>30 kg/m2) was associated with the greatest risk (HR 8.52, 95% CI 4.10-17.71, P<0.001). Conclusion Weight loss is a strong predictor of death in patients with RA. These observations may explain the observed obesity paradox and do not support a biologically protective role of obesity.

Original languageEnglish (US)
Pages (from-to)1711-1717
Number of pages7
JournalArthritis and Rheumatology
Volume67
Issue number7
DOIs
StatePublished - Jul 1 2015

Fingerprint

Weight Loss
Rheumatoid Arthritis
Body Mass Index
Obesity
Veterans
Confidence Intervals
Mortality
Electronic Health Records
Proportional Hazards Models
Medical Records
Registries
Comorbidity
Smoking
Odds Ratio
Demography
Population

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis. / Baker, Joshua F.; Billig, Erica; Michaud, Kaleb D; Ibrahim, Said; Caplan, Liron; Cannon, Grant W.; Stokes, Andrew; Majithia, Vikas; Mikuls, Ted R.

In: Arthritis and Rheumatology, Vol. 67, No. 7, 01.07.2015, p. 1711-1717.

Research output: Contribution to journalArticle

Baker, JF, Billig, E, Michaud, KD, Ibrahim, S, Caplan, L, Cannon, GW, Stokes, A, Majithia, V & Mikuls, TR 2015, 'Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis', Arthritis and Rheumatology, vol. 67, no. 7, pp. 1711-1717. https://doi.org/10.1002/art.39136
Baker, Joshua F. ; Billig, Erica ; Michaud, Kaleb D ; Ibrahim, Said ; Caplan, Liron ; Cannon, Grant W. ; Stokes, Andrew ; Majithia, Vikas ; Mikuls, Ted R. / Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis. In: Arthritis and Rheumatology. 2015 ; Vol. 67, No. 7. pp. 1711-1717.
@article{ae8efb4c8be44a18aa82a104d3cd3b3b,
title = "Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis",
abstract = "Objective In contrast to what is observed in the general population, a low body mass index (BMI) has been associated with accelerated mortality in patients with rheumatoid arthritis (RA). The aim of this study was to assess whether weight loss might explain these seemingly paradoxical observations. Methods Our study included patients identified from the Veterans Affairs (VA) RA Registry. Dates of death were abstracted from VA electronic medical records. The BMI at each study visit and the change from the previous visit were determined. The maximum BMI of each patient was also obtained from medical records. The annualized rate of BMI loss was determined from the slope of change (per year) in BMI over visits within the preceding 13 months. Cox multivariable proportional hazards models were used to assess associations between BMI measures and mortality. Results In a sample of 1,674 patients, 312 deaths occurred over 9,183 person-years. A loss in BMI of ≥1 kg/m2 was associated with a greater risk of death, after adjustment for demographics, comorbidities, BMI, smoking, and RA therapies (hazard ratio [HR] 1.99, 95{\%} confidence interval [95{\%} CI] 1.53-2.59, P<0.001). This association remained significant in a subsample analysis adjusting for C-reactive protein and physical function (HR 1.81, 95{\%} CI 1.36-2.41, P<0.001). Weight loss at an annualized rate of ≥3 kg/m2 was associated with the greatest risk of death (HR 2.49, 95{\%} CI 1.73-3.57, P<0.001). Low BMI (<20 kg/m2) in patients with a history of obesity (>30 kg/m2) was associated with the greatest risk (HR 8.52, 95{\%} CI 4.10-17.71, P<0.001). Conclusion Weight loss is a strong predictor of death in patients with RA. These observations may explain the observed obesity paradox and do not support a biologically protective role of obesity.",
author = "Baker, {Joshua F.} and Erica Billig and Michaud, {Kaleb D} and Said Ibrahim and Liron Caplan and Cannon, {Grant W.} and Andrew Stokes and Vikas Majithia and Mikuls, {Ted R}",
year = "2015",
month = "7",
day = "1",
doi = "10.1002/art.39136",
language = "English (US)",
volume = "67",
pages = "1711--1717",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis

AU - Baker, Joshua F.

AU - Billig, Erica

AU - Michaud, Kaleb D

AU - Ibrahim, Said

AU - Caplan, Liron

AU - Cannon, Grant W.

AU - Stokes, Andrew

AU - Majithia, Vikas

AU - Mikuls, Ted R

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Objective In contrast to what is observed in the general population, a low body mass index (BMI) has been associated with accelerated mortality in patients with rheumatoid arthritis (RA). The aim of this study was to assess whether weight loss might explain these seemingly paradoxical observations. Methods Our study included patients identified from the Veterans Affairs (VA) RA Registry. Dates of death were abstracted from VA electronic medical records. The BMI at each study visit and the change from the previous visit were determined. The maximum BMI of each patient was also obtained from medical records. The annualized rate of BMI loss was determined from the slope of change (per year) in BMI over visits within the preceding 13 months. Cox multivariable proportional hazards models were used to assess associations between BMI measures and mortality. Results In a sample of 1,674 patients, 312 deaths occurred over 9,183 person-years. A loss in BMI of ≥1 kg/m2 was associated with a greater risk of death, after adjustment for demographics, comorbidities, BMI, smoking, and RA therapies (hazard ratio [HR] 1.99, 95% confidence interval [95% CI] 1.53-2.59, P<0.001). This association remained significant in a subsample analysis adjusting for C-reactive protein and physical function (HR 1.81, 95% CI 1.36-2.41, P<0.001). Weight loss at an annualized rate of ≥3 kg/m2 was associated with the greatest risk of death (HR 2.49, 95% CI 1.73-3.57, P<0.001). Low BMI (<20 kg/m2) in patients with a history of obesity (>30 kg/m2) was associated with the greatest risk (HR 8.52, 95% CI 4.10-17.71, P<0.001). Conclusion Weight loss is a strong predictor of death in patients with RA. These observations may explain the observed obesity paradox and do not support a biologically protective role of obesity.

AB - Objective In contrast to what is observed in the general population, a low body mass index (BMI) has been associated with accelerated mortality in patients with rheumatoid arthritis (RA). The aim of this study was to assess whether weight loss might explain these seemingly paradoxical observations. Methods Our study included patients identified from the Veterans Affairs (VA) RA Registry. Dates of death were abstracted from VA electronic medical records. The BMI at each study visit and the change from the previous visit were determined. The maximum BMI of each patient was also obtained from medical records. The annualized rate of BMI loss was determined from the slope of change (per year) in BMI over visits within the preceding 13 months. Cox multivariable proportional hazards models were used to assess associations between BMI measures and mortality. Results In a sample of 1,674 patients, 312 deaths occurred over 9,183 person-years. A loss in BMI of ≥1 kg/m2 was associated with a greater risk of death, after adjustment for demographics, comorbidities, BMI, smoking, and RA therapies (hazard ratio [HR] 1.99, 95% confidence interval [95% CI] 1.53-2.59, P<0.001). This association remained significant in a subsample analysis adjusting for C-reactive protein and physical function (HR 1.81, 95% CI 1.36-2.41, P<0.001). Weight loss at an annualized rate of ≥3 kg/m2 was associated with the greatest risk of death (HR 2.49, 95% CI 1.73-3.57, P<0.001). Low BMI (<20 kg/m2) in patients with a history of obesity (>30 kg/m2) was associated with the greatest risk (HR 8.52, 95% CI 4.10-17.71, P<0.001). Conclusion Weight loss is a strong predictor of death in patients with RA. These observations may explain the observed obesity paradox and do not support a biologically protective role of obesity.

UR - http://www.scopus.com/inward/record.url?scp=84933074031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933074031&partnerID=8YFLogxK

U2 - 10.1002/art.39136

DO - 10.1002/art.39136

M3 - Article

C2 - 25940140

AN - SCOPUS:84933074031

VL - 67

SP - 1711

EP - 1717

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 7

ER -